SHS Capital

SHS Capital, founded in 1993 and based in Tübingen, is an independent private equity firm specializing in investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors. Recognized as a leading healthcare growth investor in Germany, SHS has managed five generations of funds and invested in over 50 companies throughout Western Europe. Currently, the firm is actively investing through its fourth and fifth generation funds, with the latest fund still open for subscription. SHS Capital targets both young, high-growth companies and established firms, facilitating small buyouts and growth financing to support their development.

Friedrich Baldinger

Senior Investment Manager

Patrick Frohnheiser

Investment Manager

Cornelius Maas

Partner

Uwe Steinbacher

Managing Partner

Manfred Ulmer-Weber

Partner

David Wehner

Senior Investment Manager

André Zimmermann

Partner

60 past transactions

Single Use Support

Venture Round in 2019
SINGLE USE SUPPORT GMBH manufactures heavy duty single use plastic containers for fluid logistics processes. The company also develops bulk filling systems for liquids for transportation in single use bags. Its bulk filling systems include BULK.STREAM and RoSS.FILL. The company was founded in 2015 and is headquartered in Kufstein, Austria.

Miracor Medical

Series D in 2018
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.

Incision

Series A in 2021
Incision is a developer of a medical education platform built to offer a standardized method of how to perform a procedure in practical steps and sub-steps.

Blazejewski MEDI-TECH

Private Equity Round in 2020
Blazejewski MEDI-TECH GmbH develops, manufactures, and distributes private label medical endoscopes and visualization units for minimally invasive and surgical applications. It offers endoscopes with and without working channels, 3D stereoscopy products, rigid endoscopes, angled optics, semi-flexible endoscopes, and OEM electronics. The company serves original equipment manufacturers in Germany and internationally. Blazejewski MEDI-TECH GmbH was founded in 1991 and is based in Emmendingen, Germany.

Puracon

Acquisition in 2016
Puracon provides medical packaging and logistics services in Germany. It offers contract packaging services, including inspection and cleaning, assembling, packaging, sterilization, and validations for medical products; logistics services, such as full-service, storage, and shipping; and consulting services, including support for product approvals. Puracon provides services in the areas of medical technology, pharmacology, and biotechnology. It began operation in 2003, with its headquarters in Rosenheim in Germany.

Blazejewski MEDI-TECH

Private Placement in 2020
Blazejewski MEDI-TECH GmbH develops, manufactures, and distributes private label medical endoscopes and visualization units for minimally invasive and surgical applications. It offers endoscopes with and without working channels, 3D stereoscopy products, rigid endoscopes, angled optics, semi-flexible endoscopes, and OEM electronics. The company serves original equipment manufacturers in Germany and internationally. Blazejewski MEDI-TECH GmbH was founded in 1991 and is based in Emmendingen, Germany.

TNI medical

Private Placement in 2018
TNI medical AG develops, produces, and markets diagnostic and therapeutic equipment for respiratory assistance therapy. Its TNI SoftFlow System provides respiratory support to patients. The company offers its products through its Internet based platform in Würzburg, Dessau, and Baltimore. The company was founded in 2007 and is headquartered in WÜrzburg, Germany. As of March 30, 2020, TNI medical AG operates as a subsidiary of Masimo Corporation.

GNA Biosolutions

Series B in 2015
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.

Phenox

Venture Round in 2010
Phenox develops and produces neuroradiological and radiological medical products. It offers instruments for acute ischemic strokes/aneurysmen that include pCR, a miniature instrument, which aids the restoration of blood-flow in the area of the brain arteries affected by an acute ischemic stroke; CRC, a mechanical thrombectomy system for the treatment of acute ischemic strokes; BONNET for the treatment of acute ischemic strokes; BONNET short, an intracranial flow restoration device; p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections, pCONUS Bifurcation Aneurysm Implant, to treat complex, wide neck intracranial bifurcation aneurysms; pITA RX Neurovascular PTA Balloon Catheter; and pRESET, a thrombectomy retriever for the treatment of acute ischemic strokes. Phenox also provides implants for hemorrhagic strokes/aneurysmen, including flow diverters and pORTAL Hydrophilic Steerable Guidewire. It distributes its products in Germany and internationally. Phenox began operation in 2005. It has its headquarters in Bochum in Germany.

Medigroba

Acquisition in 2016
Medigroba GmbH provides healthcare services. The Company specializes in the care of patients in hospitals, nursing facilities, and at home. Medigroba serves patients in Germany.

Miracor Medical

Series B in 2011
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.

Spiegelberg

Acquisition in 2011
Spiegelberg develops, produces, and sells catheters and probes for neurosurgical use in the brain as well as antimicrobial products to prevent hospital acquired infections. It began operation in 1986, with its headquarters in Hamburg in Germany.

Neuro Event Labs

Private Placement in 2020
Neuro Event Labs is a Finnish medical technology growth company. The company’s main product monitors epilepsy patients at home and in hospital. Accurate epilepsy seizure data is collected, analyzed and relayed to the patient’s physician, who makes individual treatment decisions based on the reports. The solution has been developed on close cooperation with leading Finnish hospitals.

GNA Biosolutions

Series C in 2019
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.

medigroba GmbH

Merger/Acquisition in 2016
medigroba GmbH provides home healthcare services. It supplies patients in hospitals, nursing facilities, and at home with medical aid and care services and products for home respiration, wound and stoma treatment, liquid, probe, and intravenous nutrition, pain therapy, and children's intensive care. The company provides in-house training and qualification to its employees as well as external specialists. The company was founded in 1975 and is based in Balingen, Germany.

TNI medical

Acquisition in 2010
TNI medical AG develops, produces, and markets diagnostic and therapeutic equipment for respiratory assistance therapy. Its TNI SoftFlow System provides respiratory support to patients. The company offers its products through its Internet based platform in Würzburg, Dessau, and Baltimore. The company was founded in 2007 and is headquartered in WÜrzburg, Germany. As of March 30, 2020, TNI medical AG operates as a subsidiary of Masimo Corporation.

Arzneimittelwerk Warngau

Series C in 2016
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

c-LEcta

Series C in 2008
c-LEcta GmbH operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. The company develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. It offers DENARASE, a genetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. c-LEcta GmbH was founded in 2004 and is based in Leipzig, Germany.

Tyromotion

Seed Round in 2016
Tyromotion GmbH manufactures and distributes robotic assisted and computer aided therapy units. It develops rehabilitation technologies by employing mechatronic systems. The company focuses on developing Amadeo System, a mechatronic rehabilitation device, which is used in the rehabilitation of patients exhibiting motor dysfunctions of the distal upper extremity. Tyromotion GmbH was founded in 2007 and is based in Graz, Austria with additional office in New York, New York.

evitria

Venture Round in 2018
evitria AG engages in the research and development of protein design and expression products. It offers carbon hydrogen oxygen (CHO) based antibodies for protein design, transient gene expression, and stable cell lines. The company also offers a protein expression platform which allows fast production of gram quantities of protein in HEK293 and CHO cells and helps in adeno-associated virus (AAV) and lentivirus-mediated gene transfer. The company was founded in 2010 and is based in Schlieren, Switzerland.

Puracon

Merger/Acquisition in 2016
Puracon provides medical packaging and logistics services in Germany. It offers contract packaging services, including inspection and cleaning, assembling, packaging, sterilization, and validations for medical products; logistics services, such as full-service, storage, and shipping; and consulting services, including support for product approvals. Puracon provides services in the areas of medical technology, pharmacology, and biotechnology. It began operation in 2003, with its headquarters in Rosenheim in Germany.

Vimecon

Venture Round in 2014
Vimecon GmbH develops and produces laser catheter for the treatment of heart diseases with a focus on Atrial Fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. In addition, Vimecon GmbH advises various customers from the scholar and industrial research and development. The company was founded in 2005 and is based in Herzogenrath, Germany.

Emerging Implant Technologies

Venture Round in 2016
Emerging Implant Technologies designs and manufactures medical implants in the field of orthopedics. Its products include EIT cervical cages, EIT PLIF cages, and EIT TLIF cages. Emerging Implant Technologies began operation in 2014, with its headquarters in Tuttlingen in Germany. Emerging Implant Technologies operates as a subsidiary of Johnson & Johnson Medical as of September 12, 2018.

SIS-Schwager Group

Acquisition in 2015
SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. It began operation in 2005, with its headquarters in Winterthur in Switzerland.

CoreMedic AG

Venture Round in 2017
CoreMedic AG develops and manufactures devices and therapies to address the treatment of heart valve diseases. The company offers ChordArt, a mitral valve repair system which focuses on the minimally invasive, trans-femoral repair at the beating heart. It is developing two systems which facilitate delivery and deployment of the implant. Additionally, the company provides ChordArt S, which reduces invasiveness of the surgical procedure by repairing the valve in a way which allows the surgeon to focus on the procedure and timing rather than manually placing the sutures to repair the valve; and ChordArt C which allows for the valve repair to be carried out via the vascular route through a tiny incision in the groin. CoreMedic AG was founded in 2012 and is headquartered in Biel/Bienne, Switzerland.

SIS SCHWAGER Group

Merger/Acquisition in 2015
SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. The company was founded in 2005 and is based in Winterthur, Switzerland.

Betterguards

Venture Round in 2019
Betterguards is a Berlin-Brandenburg-based start-up that changes the way avoid and treat acute injuries to joints or ligaments. Like a seatbelt the Betterguards Technology allows a high range of motion while joints are effectively protected from injury-causing movements.

TRI Dental Implants

Venture Round in 2014
TRI Dental Implants develops, designs, and manufactures dental implant systems. Its products include soft tissue concept, friction, and bone adaptation, as well as sandblasted, large grit, and acid-etched (SBA) surface implant systems; vent implant line of products; narrow implants; octa implants; prosthetic portfolio of products; and surgical kits for surgeons. TRI Dental Implants offers its products through a network of distributors in Australia, China, Columbia, Egypt, Greece, Hong Kong, Iraq, Iran, Lebanon, Morocco, the Netherlands, Portugal, Romania, the Russian Federation, Saudi Arabia, Serbia, Taiwan, Turkey, and the United Arab Emirates; and directly to customers in Germany, Italy, France, Hungary, and the United Kingdom. It also enables customers to order products online. Tobias S. Richter founded TRI Dental Implants on December 1, 2010. It has its headquarters in Baar in Switzerland.

Single Use Support

Merger/Acquisition in 2019
SINGLE USE SUPPORT GMBH manufactures heavy duty single use plastic containers for fluid logistics processes. The company also develops bulk filling systems for liquids for transportation in single use bags. Its bulk filling systems include BULK.STREAM and RoSS.FILL. The company was founded in 2015 and is headquartered in Kufstein, Austria.

Les Delices des 7 Vallees

Venture Round in 2015
SAS Délices des 7 Vallées produces frozen cakes and pastries. The company was founded in 1996 and is headquartered in Tincques, France. As of December 20, 2018, SAS Délices des 7 Vallées operates as a subsidiary of Mademoiselle Desserts SAS.

CryLaS

Venture Round in 2004
CryLaS designs and manufactures diode-pumped solid-state lasers in the UV, VIS, and IR for scientific and original equipment manufacturing use. It offers lasers in the UV, VIS, and IR ranges of the spectrum that are used in spectroscopy, environmental technology, analysis, and photolithography; and pulsed and CW-lasers based solely on solid state technology. CryLaS' products have applications in biotechnology, analytics, imaging, sensor systems, and micromachining. It sells its products through its distributor in Germany, Austria, Switzerland, the United States, Canada, Middle and South America, the United Kingdom, France, Spain, Italy, Japan, China, Italy, Singapore, Malaysia, Taiwan, Israel, and India. CryLaS began operation in 2004. It has its headquarters in Berlin in Germany.

MESI

Venture Round in 2023
ABPI MD allows screening for peripheral artery disease to all patients older than 50 years. Until now it was impossible as measurement was manually performed, it lasted for 30 minutes it required a doctor and it was inaccurate. With ABPI MD diagnostic is performed automatically in 3 minutes it is objective and accurate and it can be performed by a medical nurse. International guidelines for Peripheral artery disease advise that the screening has to be performed to every patient older than 50 years and with our device it is possible to fulfil the guidelines.

Incision

Series A in 2021
Incision is a developer of a medical education platform built to offer a standardized method of how to perform a procedure in practical steps and sub-steps.

Betterguards

Private Placement in 2019
Betterguards is a Berlin-Brandenburg-based start-up that changes the way avoid and treat acute injuries to joints or ligaments. Like a seatbelt the Betterguards Technology allows a high range of motion while joints are effectively protected from injury-causing movements.

Incision

Series A in 2021
Incision is a developer of a medical education platform built to offer a standardized method of how to perform a procedure in practical steps and sub-steps.

GNA Biosolutions GmbH

Private Placement in 2019
GNA Biosolutions GmbH manufactures ultrafast pathogen diagnostic instruments. The company develops assays and instruments for ultrafast detection of biomolecules, based on GNA optothermal NANOSTOVE technology. It offers Pharos V8, a PCR platform that rely on thermocyclers that limit the speed of the reaction and Pulse Controlled Amplification (PCA), a platform designed for time sensitive molecular applications. GNA Biosolutions GmbH was founded in 2010 and is based in Munich, Germany.

Dr.Dropin

Venture Round in 2022
Developer of a private digital healthcare platform designed to democratise the private healthcare market and provide healthcare services. The company's one-stop shop platform offers general medicine, specialist health services, dermatologists, physical therapists, psychologists and other medical issues covering a wide range of diseases, thereby enabling patients with instant access to care services at an affordable price, both physically and digitally.

Selfapy

Private Placement in 2020
Selfapy GmbH develops an online therapy program for people affected by depression. The company offers therapy related programs, such as anxiety and panic programs, depression programs, eating disorder habits, stress and mindfulness, and chronic panic programs. It delivers 3 months of therapy solutions via phone or SMS function. The company offers exercises, videos, and texts. Selfapy GmbH was formerly known as Selfapy UG. The company was founded in 2016 and is headquartered in Berlin, Germany.

PathoQuest

Series B in 2021
PathoQuest SAS, a biotechnology company, offers a game changing metagenomics approach to improving the breadth of pathogen detection. The company offers products, such as (NGS) based testing approach delivers actionable reports to clinicians, biologists, and biopharmaceutical quality assurance managers and production managers. It provides iDTECTTM Dx Blood test, an approach to the identification of pathogens and iDTECTTM database and software suite that enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. The company also offers Viral Safety testing service for biopharmaceutical companies. It has strategic alliance with Charles River Laboratories International, Inc. PathoQuest SAS was founded in 2010 and is based in Paris, France.

Develco Pharma Schweiz AG

Private Placement in 2020
Develco Pharma Schweiz AG engages in the development and manufacture of pharmaceutical ingredients. The company also provides sourcing, project management, analytical and clinical development, and registration services. It develops solid dosage forms. The company was incorporated in 2006 and is based in Binningen, Switzerland. Develco Pharma Schweiz AG has laboratory facilities in Schopfheim, Germany.

numares AG

Venture Round in 2009
numares AG develops and markets software-based test systems for clinical diagnostics and life science research. Its AXINON in vitro diagnostic (IVD) system and diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a numeric spectrum to evaluate metabolomic networks. The output from these analyses provides information on the disease status of patients to physicians. The company uses magnetic group signaling (MGS) technology for NMR based testing solution for diagnostics in the areas of cardiovascular diseases, nephrology, oncology, and neurology. numares AG was founded in 2004 and is based in Regensburg, Germany.

NDD Medizintechnik

Merger/Acquisition in 2015
ndd Medizintechnik AG manufactures pulmonary function testing products. It offers EasyOne Worldspirometer, a portable spirometer for testing; and EasyOne Pro LAB that offers spirometry, single-breath CO diffusion, and multi-breath nitrogen washout. The company also provides EasyOne Pro, a spirometry and single-breath co diffusion solution; EasyOne-Line, a spirometer with direct connectivity to the PC; and Easy on-PC, a PC spirometry solution. In addition, it offers accessories, such as disposable spirettes and barriers.

Salvia BioElectronics

Series A in 2020
Salvia is a young innovative start-up company active in the emerging field of “BioElectronics” that is inspired by biology and electronics to provide innovative therapeutic solutions. The name Salvia is derived from the Latin word salvere, which means "to stay healthy".​They are driven to deliver bioelectronic solutions that restore health for people suffering from severe neurologic disorders; their ambition is to make these novel therapies widely accessible. The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).

Salvia BioElectronics

Private Placement in 2020
Salvia is a young innovative start-up company active in the emerging field of “BioElectronics” that is inspired by biology and electronics to provide innovative therapeutic solutions. The name Salvia is derived from the Latin word salvere, which means "to stay healthy".​They are driven to deliver bioelectronic solutions that restore health for people suffering from severe neurologic disorders; their ambition is to make these novel therapies widely accessible. The Salvia team consists of experienced entrepreneurs, engineers and scientists with diverse professional backgrounds and proven track-record throughout the medical device industry (Sapiens, Medtronic, Philips, St Jude, BioSensors International, Kyphon, etc).

Novo Klinik-Service

Merger/Acquisition in 2015
Novo Klinik-Service develops and produces fixations and pads for intensive care, anesthetic, and nursing sectors in Germany and internationally. It offers tracheostomy/laryngectomy–fixations and accessories, ventilation–fixations and accessories, and securement devices and prophylaxis; Novobil One, an ultra-light trolley that fits in various elevators; and ITS-Novo, a modular intensive care patient room. Novo Klinik-Service began operation in 1987. It has its headquarters in Kerpen in Germany.

Selfapy

Series A in 2020
Selfapy GmbH develops an online therapy program for people affected by depression. The company offers therapy related programs, such as anxiety and panic programs, depression programs, eating disorder habits, stress and mindfulness, and chronic panic programs. It delivers 3 months of therapy solutions via phone or SMS function. The company offers exercises, videos, and texts. Selfapy GmbH was formerly known as Selfapy UG. The company was founded in 2016 and is headquartered in Berlin, Germany.

Novo Klinik-Service

Acquisition in 2015
Novo Klinik-Service develops and produces fixations and pads for intensive care, anesthetic, and nursing sectors in Germany and internationally. It offers tracheostomy/laryngectomy–fixations and accessories, ventilation–fixations and accessories, and securement devices and prophylaxis; Novobil One, an ultra-light trolley that fits in various elevators; and ITS-Novo, a modular intensive care patient room. Novo Klinik-Service began operation in 1987. It has its headquarters in Kerpen in Germany.

Arzneimittelwerk Warngau

Series B in 2015
Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

numares AG

Venture Round in 2011
numares AG develops and markets software-based test systems for clinical diagnostics and life science research. Its AXINON in vitro diagnostic (IVD) system and diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a numeric spectrum to evaluate metabolomic networks. The output from these analyses provides information on the disease status of patients to physicians. The company uses magnetic group signaling (MGS) technology for NMR based testing solution for diagnostics in the areas of cardiovascular diseases, nephrology, oncology, and neurology. numares AG was founded in 2004 and is based in Regensburg, Germany.
AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser, robotics and navigation systems to re-invent bone surgery (osteotomy).

Miracor Medical

Private Placement in 2018
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.

Advanced Osteotomy Tools AG

Venture Round in 2015
AOT AG is a privately owned Swiss Robotic Surgery company, which spun out of the University Hospital and the University Basel (Switzerland) in 2011 and was first funded in 2012. The company is dedicated to the development, manufacturing and sales of medical devices for osteotomy pursuing the vision of contact-free bone surgery using laser, robotics and navigation systems to re-invent bone surgery (osteotomy).

Miracor Medical

Series B in 2015
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.

Micropelt

Series A in 2006
Micropelt started as a project of Infineon Technologies AG in cooperation with the Fraunhofer Institute for Physical Measurement Techniques (Fraunhofer IPM) in Freiburg (Germany). Now it is a StartUp which is funded by SHS, MBG, KfW Mittelstandsbank, L-Bank and IBG. Their team develops thin film thermoelectric components based on semiconductor manufacturing processes.

Miracor Medical

Series C in 2016
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.

Biontis

Venture Round in 2008
Biontis GmbH develops automated processes for biochemical analysis of complex liquid mixtures. It also makes laboratory equipment. The company’s products are used in laboratories for water analysis and food inspections, forensic medicine, and clinical diagnostics applications. It markets its products in Germany. The company was founded in 2002 and is based in Geesthacht, Germany.

Neuro Event Labs

Series A in 2020
Neuro Event Labs is a Finnish medical technology growth company. The company’s main product monitors epilepsy patients at home and in hospital. Accurate epilepsy seizure data is collected, analyzed and relayed to the patient’s physician, who makes individual treatment decisions based on the reports. The solution has been developed on close cooperation with leading Finnish hospitals.

NDD Medizintechnik

Venture Round in 2015
ndd Medizintechnik AG manufactures pulmonary function testing products. It offers EasyOne Worldspirometer, a portable spirometer for testing; and EasyOne Pro LAB that offers spirometry, single-breath CO diffusion, and multi-breath nitrogen washout. The company also provides EasyOne Pro, a spirometry and single-breath co diffusion solution; EasyOne-Line, a spirometer with direct connectivity to the PC; and Easy on-PC, a PC spirometry solution. In addition, it offers accessories, such as disposable spirettes and barriers.

PathoQuest

Series B in 2021
PathoQuest SAS, a biotechnology company, offers a game changing metagenomics approach to improving the breadth of pathogen detection. The company offers products, such as (NGS) based testing approach delivers actionable reports to clinicians, biologists, and biopharmaceutical quality assurance managers and production managers. It provides iDTECTTM Dx Blood test, an approach to the identification of pathogens and iDTECTTM database and software suite that enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. The company also offers Viral Safety testing service for biopharmaceutical companies. It has strategic alliance with Charles River Laboratories International, Inc. PathoQuest SAS was founded in 2010 and is based in Paris, France.